Please login to the form below

Not currently logged in
Email:
Password:

prevention

This page shows the latest prevention news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

The antibody - which targets and inhibits plasma kallikrein - is intended as a treatment for the prevention of angioedema attacks in patients 12 years and older with HAE, a rare and sometimes

Latest news

  • ViiV’s two-drug HIV combo backed by CHMP ViiV’s two-drug HIV combo backed by CHMP

    There was bad news for three other companies, with the CHMP issuing negative opinions for Portola’s Dexxience (betrixaban) for the prevention of venous thromboembolism, Radius International’s osteoporosis candidate Eladynos

  • Bad news for Portola as CHMP considers Factor Xa drugs Bad news for Portola as CHMP considers Factor Xa drugs

    The CHMP communicated a negative trend vote for betrixaban for the prevention of venous thromboembolism (VTE) in adult patients hospitalised for an acute medical illness with risk factors for VTE, ”said

  • EMA set to review Teva’s migraine injection EMA set to review Teva’s migraine injection

    The European Medicines Agency (EMA) has accepted Teva’s marketing authorisation application (MAA) for its migraine prevention medicine fremanezumab. ... Fremanezumab is also being investigated for the prevention of chronic and episodic cluster headache

  • EC grants MSD’s Prevymis orphan product designation EC grants MSD’s Prevymis orphan product designation

    The European Commission has granted Merck Sharp &Dohme’s new CMV prevention medication orphan medicinal product status, handing it a package of benefits that will include some market exclusivity.

  • Takeda gets FDA fast-track status for Zika vaccine Takeda gets FDA fast-track status for Zika vaccine

    An outbreak of the virus in Brazil in 2015-16 resulted in almost 2, 000 infants born with microcephaly, while the US Centers for Disease Control and Prevention (CDC) says there

More from news
Approximately 4 fully matching, plus 752 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified across 15 states of the USA.

  • A new era of smart pharma A new era of smart pharma

    SAEs). It is in this area that pharmacovigilance, the science relating to the collection, detection, assessment, monitoring and prevention of adverse effects with pharmaceutical products, is making a difference.

  • Waking the sleeping giant Waking the sleeping giant

    A Lancet Commission, to complement this, has pointed out that ‘the rapid expansion of new, African-bred approaches to people-centred health systems, focused on prevention, primary care and public health,

  • When is it time to rebrand? When is it time to rebrand?

    Marketing campaigns are being replaced by branding initiatives. Pharma has become more patient-centric - with brands investing more in disease awareness, prevention and education. ... We have a new market segment with new needs. We want to brand our

  • A marathon and a sprint A marathon and a sprint

    Pharma’s CX marathon involves multiple participants; prescribers, policy-makers, regulators, payers, patients, carers and, as the prevention agenda gathers pace, ‘healthy’consumers.

More from intelligence
Approximately 2 fully matching, plus 57 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Communicating the prevention message by Tam Fry

    Communicating the prevention message by Tam Fry. Tam Fry, spokesperson of the National Obesity Forum, discusses how prevention is key to tackling the childhood obesity epidemic in the UK. ... But how do we communicate the prevention message? We have made

  • The patient will see you now

    This connected ecosystem provides healthcare systems with the power to move beyond monitoring, towards disease prevention – with pharma becoming a key conduit in the transition. ... For diabetics this advancement means monitoring is 24-hours a day,

  • Raising Awareness: It’s World COPD Day today!

    awareness of COPD, and to improve treatment and prevention of this lung disease for patients around the world. ... prevention or treatment and are unware of the impact that COPD can have on a patient’ s quality of life.

  • 23andMe – is DNA screening ethical?

    to detecting cancers, so prevention and treatment can be looked at as early as possible.

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    Crenezumab, gantenerumab, and solanezumab are all involved in additional prospective  longitudinal investigations – the  Alzheimer’ s Prevention Initiative (Phase 2), the  Dominantly Inherited Alzheimer Network study (Phase 2/3), and the 

More from PMHub
Approximately 2 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics